12

Zhang XP, Wang L, Zhou YF. The pathogenic mechanism of severe acute pancreatitis complicated with renal injury: a review of current knowledge. Dig Dis Sci 2008; 53(2):297-306. [More details]

11

Wang L, Ma Q, Chen X, Sha H, Ma Z. Effects of resveratrol on calcium regulation in rats with severe acute pancreatitis. Eur J Pharmacol 2008; 580:271-6. [More details]

10

Zhang XP, Wang L. Progress in mechanism of severe acute pancreatis complicated by liver damages. World Chinese Journal of Digestology 2005; 13(11):1335-9. [More details]

9

Ikizceli I, Yurumez Y, Avsarogullari L, Kucuk C, Sozuer EM, Soyuer I, et al. Effect of interleukin-10 on pancreatic damage caused by organophosphate poisoning. Regul Toxicol Pharmacol 2005; 42(3):260-4. [More details]

8

Pitchumoni CS, Patel NM, Shah P. Factors influencing mortality in acute pancreatitis: can we alter them?. J Clin Gastroenterol 2005; 39(9):798-814. [More details]

7

Hofseth LJ, Ying L. Identifying and defusing weapons of mass inflammation in carcinogenesis. Biochim Biophys Acta 2006; 1765(1):74-84. [More details]

6

Wang G, Sun B. Current status of interleukin-10 in treatment of acute pancreatitis. Shi Jie Hua Ren Xiao Hua Za Zhi 2005; 13(1) , 69-71. [World Chinese Journal of Digestology] [More details]

5

Gottumukkala SR. Prevention of post-ERCP pancreatitis: are there any pearls for sale?. Gastroenterology 2004; 127(1):348-50. [More details]

4

Yang YL, Li JP, Li KZ, Dou KF. Tumor necrosis factor alpha antibody prevents brain damage of rats with acute necrotizing pancreatitis. World J Gastroenterol 2004; 10(19):2898-900. [More details]

3

Sun W, Zhang JD, Zhao Y, Zhao Y, Wang Q. Expression of IL-6 and integrin family cell adhesion molecules in acute necrotizing pancreatitis complicated with multiple organ injury in rats. Shi Jie Hua Ren Xiao Hua Za Zhi 2003; 11(6):753-5. [World Chinese Journal of Digestology] [More details]

2

Dumont FJ. Therapeutic potential of IL-10 and its viral homologues: an update. Expert Opin Ther Pat 2003; 13(10):1551-77. [More details]

1

Freeman ML. Prevention of post-ERCP pancreatitis: Pharmacologic solution or patient selection and pancreatic stents?. Gastroenterology 2003; 124(7):1977-80. [More details]